Search for Clinical Trial Results

Sponsored By

Primary Orthostatic Hypotension - 8 Studies Found

Status Study
Recruiting Study Name: Norepinephrine Transporter Blockade, Autonomic Failure (NETAF)
Condition: Neurogenic Orthostatic Hypotension
Date: 2016-05-24
Interventions:
  • Drug: Atomoxetine norepinephri
Completed Study Name: Study of the Fed-Fast Pharmocokinetics and Bioequivalance of 300mg Capsules of Droxidopa
Condition: Symptomatic Neurogenic Orthostatic Hypotension
Date: 2010-06-22
Interventions:
  • Drug: Droxidopa One capsule co
Completed Study Name: Treatment and Prognosis of Neurogenic Orthostatic Hypotension : A Prospective Randomized Study
Condition: Orthostatic; Hypotension, Neurogenic
Date: 2014-12-02
Interventions:
  • Drug: Midodrine Other Name: Mi
Completed Study Name: Norepinephrine Transporter Blockade as a Pathological Biomarker in Neurogenic Orthostatic Hypotension
Condition:
  • Orthostatic Hypotension
  • Pure Autonomic Failure
  • Multiple Sy
    Date: 2011-03-15
Not yet recruiting Study Name: Effects of Melatonin to Reduce Nocturnal Hypertension in Patients With Neurogenic Orthostatic Hypotension
Condition:
  • Hypotension, Orthostatic
  • Hypertension
  • Autonomic Nervous Sy
    Date: 2016-11-07
    Interventions:
    • Drug: Yohimbine Oral Yohimbine
Completed Study Name: Abdominal Binder to Treat Orthostatic Hypotension (OH) in Parkinson's Disease (PD)
Condition:
  • Parkinson's Disease
  • Neurogenic Orthostatic Hypotension in Parki
    Date: 2013-10-17
    Interventions:
    • Device: Elastic abdominal binder

Completed Study Name: A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's Disease
Condition:
  • Orthostatic Hypotension
  • Parkinson's Disease

Date: 2010-07-30
Interventions:
  • Drug: Droxidopa 100 mg and 200
Terminated Study Name: Study To Assess The Clinical Benefit Of Droxidopa In Subjects With Chronic Fatigue Syndrome
Condition:
  • Chronic Fatigue Syndrome
  • Orthostatic Hypotension
  • Neurally
    Date: 2009-09-11
    Interventions: Drug: Droxidopa Oral, 100, 200, 300, 400, 500, or 600 mg TID, duration includes up to a 2 week titration